However, the findings from these studies have translational relevance, as oHSV immunotherapy is currently being evaluated in clinical trials in patients with glioma19,37, and CD8-targeted PET imaging studies using alternative targeting moieties are being performed in cancer patients treated with various types of immunotherapy38,39. This evidence concerns the gene CD8A and cancer.